Warning Warning: I am able to write to the configuration file: /mnt/stor13-wc2-dfw1/445381/445408/www.webcastregister.com/web/content/briley/2012/register/includes/configure.php. This is a potential security risk - please set the right user permissions on this file.

The Female Health Company (FHCO)

Please create an account to view the presentations.

O.B. Parrish, Chairman & CEO
Donna Felch, VP & CFO

The Female Health Company owns certain rights to the FC2 Female Condom. FC2 is a revolutionary, female-initiated option offering women dual protection against sexually transmitted infections (S.T.I.’s), including HIV/AIDS, and unintended pregnancy. FHCO currently has the only female condom (FC2) approved by FDA and cleared for purchase by WHO. For sexually active couples, male and female condoms are the only means of preventing sexual transmission of HIV/AIDS. More than 50% of adult HIV/AIDS cases are female. HIV/AIDS is the number one cause of death globally for women 15-44 years old. FHCO’s main market is currently the public health sector, which distributes FC2 to more than 130 countries world-wide for use in prevention programs. The Company’s customer base consists primarily of a small number of customers who purchase large quantities. Due to the receipt and timing of large orders, the Company experiences some quarter to quarter fluctuation in unit sales. The Company is profitable, debt-free, and cash flow positive and has paid ten consecutive quarterly cash dividends. The last dividend (May 2012) was $0.06 per share, a 20% increase over prior quarterly dividends.

About B. Riley & Co.

B | RILEY

B. Riley is a FINRA member firm providing research and trading ideas to institutional clients and high net worth individuals, and investment banking services to a wide range of middle-market private and public companies. Founded in 1997, the firm began by successfully targeting small capitalization California-based companies and has won a reputation for providing proprietary, unbiased and often contrarian Equity and High Yield research coverage of companies that are under-followed or misunderstood by Wall Street.  At B. Riley, we are singularly focused on under-valued small to mid-cap companies on the West Coast - by identifying possibilities where no one else is looking, we achieve superior long-term returns for our clients.  For more information, please visit www.brileyco.com.

The B. Riley & Co. Conference Team conference@brileyco.com (310) 689-2228